2016. Electrocardiographic and biochemical adverse effects of meglumine antimoniate (MA) during treatment of Syrian cutaneous leishmaniasis patients. Journal of Pakistan Association of Dermatologists. 23, 4 (Dec. 2016), 412–417. DOI:https://doi.org/10.66344/jpad.v23i4.289.